Effects of a Gum Gel Intended to Treat Signs and Symptoms of Teething
Retrospective Analysis of the Effects of a Gum Gel Intended to Treat Signs and Symptoms of Teething in Infants
1 other identifier
observational
51
1 country
1
Brief Summary
Teething discomfort is a widespread disorder affecting a very high percentage of infants. The use of hyaluronic acid gels has been shown in the last 20 years to be an effective tool, generally devoid of side effects, in reducing oral mucosal inflammation in adults. Its effectiveness in infants is affected by the strength of hyaluronic acid retention over the oral mucosa. This is in turn affected by formulation and may vary between different products due to the different ingredients used. In this study, the results collected by monitoring the paediatric experience regarding a newly developed HA-based medical device, intended to counteract teething discomfort in infants, will be reported.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedFirst Submitted
Initial submission to the registry
May 4, 2021
CompletedFirst Posted
Study publicly available on registry
May 10, 2021
CompletedJuly 7, 2021
July 1, 2021
7 months
May 4, 2021
July 6, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Unexplained cry
5-level Likert scale completed by the paediatrician
1 month (1 check per week)
Irritability
5-level Likert scale completed by the paediatrician
1 month (1 check per week)
Sleep disturbance
5-level Likert scale completed by the paediatrician
1 month (1 check per week)
Inappetence
5-level Likert scale completed by the paediatrician
1 month (1 check per week)
Salivation
5-level Likert scale completed by the paediatrician
1 month (1 check per week)
Gum redness
5-level Likert scale completed by the paediatrician
1 month (1 check per week)
Fever
Number of days with fever
1 month (1 check per week)
General well-being
5-level Likert scale completed by the paediatrician
1 month (1 check per week)
Study Arms (2)
Teething Ring + Teething Gel
Teething Ring
Interventions
Dosage: application of an even coat of 1mm thickness Frequency: 5 times/day (after main meals and before sleeping) Duration: 4 weeks
The teething ring was filled with a coolant Usage: 5/10 min per time Frequency: 5 times/day Duration: 4 weeks
Eligibility Criteria
Infants, without ethnic limitations, of both sexes and between the ages of 2 and 12 months, affected by teething discomfort but considered otherwise healthy.
You may qualify if:
- Teething discomfort
- Being healthy (except for teething discomfort)
You may not qualify if:
- Being placed on one of the following therapies in the 45 days prior to the beginning of the study: immunosuppressive, cytotoxic, cortisone, antibiotics, antifungal and hormone therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Urbino Carlo Bo
Urbino, 61029, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Davide Sisti, PhD
University of Urbino "Carlo Bo"
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
May 4, 2021
First Posted
May 10, 2021
Study Start
December 1, 2018
Primary Completion
June 30, 2019
Study Completion
June 30, 2019
Last Updated
July 7, 2021
Record last verified: 2021-07